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Introduction {#sec1}
============

In pluripotent stem cells, differential expression of a network of transcription factors governs the selection of self-renewal or differentiation ([@bib15], [@bib40]). A stable pluripotent state can be induced in somatic cells by expression of four transcription factors: Oct4, Sox2, Klf4, and c-Myc ([@bib39], [@bib38]). Chromatin modifiers and remodelers and the transcriptional machinery facilitate the function of the core transcription factors during differentiation and reprogramming ([@bib5]). However, changes in transcription alone cannot achieve the proteomic requirements of pluripotency and differentiation. Notably, an initial study that generated induced pluripotent stem cells required enhanced expression of LIN28, which promotes translation by antagonizing Let7 microRNA (miRNA) function ([@bib48]). Influential RNA regulons that drive changes in the translational profile during differentiation and reprogramming can be coordinated by RNA modifications, RNA binding proteins, miRNAs, or the translation machinery ([@bib22], [@bib36], [@bib37], [@bib42], [@bib45]).

During transcription, pre-mRNA receives a series of modifications to create the 5′ mRNA cap that protects nascent transcripts from exonucleases and forms a recruitment platform for cap-binding complexes, which mediate gene expression mechanisms, including RNA splicing, nuclear export, and translation initiation ([@bib18], [@bib34], [@bib41]). The basic mRNA cap structure (cap 0) is 7-methylguanosine linked via triphosphate to the first transcribed nucleotide (X), m7G(5′)ppp(5′)X. Cap formation is catalyzed by a series of enzymes ([@bib41]). In mammals, RNGTT has triphosphatase and guanylyltransferase activities that add the guanosine cap to the nascent transcript. Subsequently, the guanosine cap is methylated on the N-7 position by RNMT-RAM, creating the mature cap 0 structure. RNMT-RAM is critical for gene expression, since the completion of cap 0 renders transcripts competent to be processed and translated.

The mammalian cap methyltransferase consists of a catalytic subunit, RNMT (RNA guanine-7 methyltransferase), and an activating subunit, RAM (RNMT-activating miniprotein) ([@bib20], [@bib41]). RNMT has basal methyltransferase activity, which RAM increases 5- to 10-fold. RNMT and RAM also stabilize each other and have only been isolated as a complex. RAM consists an N-terminal activation domain, a central RNA binding domain that increases RNA recruitment, and a C-terminal nuclear localization domain ([@bib19]). RNMT-RAM is recruited to phosphorylated RNA pol II, coordinating capping with the initiation of transcription ([@bib2], [@bib17]). Both RNMT and RAM expression was found to be required for gene expression, cell proliferation, and viability ([@bib11], [@bib20]).

Formation of the mRNA cap is incomplete on certain transcripts and regulated by cellular signaling pathways ([@bib12], [@bib13], [@bib16], [@bib23], [@bib24], [@bib29]). In yeast, incomplete mRNA caps are associated with RNA degradation, whereas in mammals, transcripts with incomplete caps can be stable but translated at a vastly reduced rate ([@bib13], [@bib16], [@bib29]). CDK1 phosphorylates and activates RNMT, coordinating G1 transcription with mRNA cap methylation ([@bib3]). The transcription factors c-Myc and E2F-1 upregulate RNA pol II phosphorylation, which increases RNMT-RAM recruitment to transcription initiation sites and stimulates mRNA cap formation ([@bib1], [@bib12], [@bib13]). c-Myc-dependent mRNA cap methylation is also dependent on upregulation of SAHH, the enzyme that hydrolyses the inhibitory byproduct of methylation ([@bib16]).

Here, we report that RNMT-RAM is regulated during embryonic stem cell (ESC) differentiation and fibroblast reprogramming. Expression of a cohort of pluripotency-associated genes is dependent on high levels of the cap methyltransferase activator RAM, present in embryonic or induced pluripotent stem cells. During differentiation, ERK1/2-dependent phosphorylation triggers RAM degradation, resulting in repression of pluripotency-associated genes and expression of differentiation-associated genes.

Results {#sec2}
=======

RNMT and RAM Are Differentially Expressed in Primary Tissues {#sec2.1}
------------------------------------------------------------

The expression of the mRNA cap methyltransferase RNMT and its activator, RAM, was investigated in a panel of mouse organs and ESCs ([Figure 1](#fig1){ref-type="fig"}A). RNMT and RAM expression varied across the panel, with the highest expression of RNMT in brain, spleen, and testis and the highest expression of RAM in heart, lung, and liver. At extremes, brain tissue had significant RNMT expression but minimal RAM expression, whereas heart tissue had minimal RNMT expression but significant RAM expression. For this analysis, polyclonal antibodies raised against full-length RNMT and RAM that recognize epitopes across the proteins were used, and therefore, loss of signal is likely due to loss of protein and not post-translational modification or specific isoform expression ([@bib2], [@bib19]). The observations made with the organ panel imply that different cell lineages will contain different RNMT to RAM ratios. Since brain tissue exhibited a high RNMT to RAM ratio, these proteins were analyzed in primary neural cells. In murine primary cortical neurons, the RNMT level was equivalent to that in ESCs, whereas the RAM level was reduced ([Figure 1](#fig1){ref-type="fig"}B). In astrocytes, RNMT and RAM expression was minimal compared to ESCs.

RAM Expression Is Reduced during Neural Differentiation {#sec2.2}
-------------------------------------------------------

Since RAM activates RNMT, reduced RAM expression was predicted to have consequences for mRNA cap formation and gene expression. We utilized an ESC differentiation protocol to investigate RAM function during neural differentiation ([Figures 1](#fig1){ref-type="fig"}C--1F, [S1](#mmc1){ref-type="supplementary-material"}A, S1B, and [S2](#mmc1){ref-type="supplementary-material"}A) ([@bib46], [@bib47]). During this protocol, the emergence of neural morphology; loss of ESC pluripotency factors Oct4, Klf4, Sox2, and Nanog; and gain of neural markers Nestin, Sox1 (observed by GFP Sox1 locus knockin, *Sox1*^*Gt(EGFP)Asmi*^), and Pax6 confirmed differentiation into neural precursors ([@bib4]). During differentiation, the reduction in Klf4 and Nanog protein levels reflected changes in transcript levels, implying predominantly transcriptional control of these genes ([Figures 1](#fig1){ref-type="fig"}E, 1F, and [S2](#mmc1){ref-type="supplementary-material"}A). However, Oct4 and Sox2 protein levels were maintained from day 1 to 5/6 of differentiation, despite transcript levels falling significantly during this period ([Figures 1](#fig1){ref-type="fig"}E and 1F). This implies significant post-transcriptional control of Oct4 and Sox2 during the initial days of differentiation, maintenance of Oct4 and Sox2 translation rates, and/or inhibition of protein degradation.

During neural differentiation, RNMT protein levels decreased slightly, whereas RAM protein levels decreased significantly by day 5 ([Figures 1](#fig1){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}A), resulting in a high RNMT to RAM ratio, which was also observed in brain tissue and cortical neurons ([Figures 1](#fig1){ref-type="fig"}A and 1B). RAM transcript levels were maintained during neural differentiation, and therefore, RAM protein is reduced by a post-transcriptional mechanism ([Figure 1](#fig1){ref-type="fig"}F). Similar reductions in RNMT and RAM expression were observed during differentiation of human SA181 ESCs into neural precursors ([Figure S3](#mmc1){ref-type="supplementary-material"}) ([@bib9]). Loss of SOX2 and OCT4 expression, gain of PAX6 and βIII-tubulin, and the appearance of neurites indicated loss of pluripotency and induction of the neural phenotype ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C). During differentiation, RNMT expression reduced slightly whereas RAM expression was minimal by day 7 ([Figure S3](#mmc1){ref-type="supplementary-material"}B). As in murine ESC differentiation, a reduction in RAM transcripts did not accompany loss of RAM protein, which is therefore repressed by a post-transcriptional mechanism ([Figure S3](#mmc1){ref-type="supplementary-material"}C).

In order to understand the consequences of reduced RAM expression, it was important to determine whether in ESCs RAM functions only in a complex with RNMT or also functions as a monomer or in other complexes. In previously investigated cell lines, RAM was only observed in a complex with RNMT ([@bib20]). In ESCs, RAM monomers were not detected by gel filtration ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Using reciprocal immunoprecipitations (IPs), RNMT and RAM were found in a complex ([Figure S2](#mmc1){ref-type="supplementary-material"}C). RNMT IP significantly depleted RAM from cell extracts, whereas RAM IP only partially depleted RNMT, consistent with the majority of RAM being complexed with RNMT. A likely scenario is that during differentiation, RNMT-RAM complexes decrease and RNMT monomers increase. Consistent with a reduction in RAM, day 5 neural precursors exhibited reduced cap methyltransferase activity compared to day 4 ([Figure S2](#mmc1){ref-type="supplementary-material"}D).

RAM Is Important for mRNA Translation and Oct4, Sox2, and Klf4 Expression {#sec2.3}
-------------------------------------------------------------------------

We investigated whether the high RAM levels in ESCs have biological significance. RAM expression was reduced by small interfering RNA (siRNA) transfection, reproducing the minimal expression observed in neural cells ([Figure 2](#fig2){ref-type="fig"}A). Since the mRNA cap and mRNA cap methyltransferase can affect mRNA transcription, stability, processing, export, and translation initiation, the effect of RAM reduction on the net output of these events, the translational profile, was investigated. Equivalent numbers of ESCs were plated and transfected with RAM siRNA or control, and 48 hr, later native RNA-protein complexes were separated by centrifugation through a sucrose gradient and detected by UV absorbance ([Figure S4](#mmc1){ref-type="supplementary-material"}A). The experiment was performed on four independent occasions, and the RNA content of fractions was quantitated ([Figures 2](#fig2){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}B). Free ribosomes and ribosomal subunits (monosomes) were separated from translating RNA-ribosome complexes (polysomes). Reduced RAM expression resulted in a significant reduction in the ratio of polysomes to monosomes, indicating reduced ribosome loading of mRNA and a translation defect ([Figure 2](#fig2){ref-type="fig"}C). Note that transfection of RAM siRNA in this experimental protocol resulted in a small reduction in cell number after 2 days (14.3%, 4.3%SD), accounting for the reduced monosome peak in RAM siRNA-treated cells ([Figure S4](#mmc1){ref-type="supplementary-material"}C).

We investigated the biological impact of RAM on ESCs. Alkaline phosphatase staining can be used as a marker of pluripotency ([@bib28]). On plating ESCs at clonal density, inhibition of RAM resulted in a significant decrease in alkaline phosphatase-positive colonies and an increase in mixed and negative colonies ([Figures 2](#fig2){ref-type="fig"}D, [S4](#mmc1){ref-type="supplementary-material"}D, and S4E). Immunofluorescence (IF) analysis indicated that suppression of RAM resulted in reduced expression of the pluripotency-associated transcription factors Sox2 and Oct4, whereas Nanog expression was minimally repressed ([Figures 2](#fig2){ref-type="fig"}E and 2F). Western blot analysis of cell extracts confirmed significant repression of Sox2 and Oct4, but not Nanog, protein expression in multiple independent experiments ([Figure 2](#fig2){ref-type="fig"}G). Another pluripotency-associated transcription factor, Klf4, was also significantly repressed in response to RAM suppression.

Oct4, Sox2, and Klf4 may be directly or indirectly dependent on RAM for expression. We confirmed that reduced RAM expression results in loss of cap methylation of Oct4, Sox2, and Klf4 transcripts ([Figure 2](#fig2){ref-type="fig"}H). The proportion of transcripts with an m7G cap is detected by a semiquantitative method in which m7G-RNA is subject to IP and transcripts detected by RT-PCR (Nanog was not amenable to this technique, potentially due to secondary structure) ([@bib12]). These data indicate that Oct4, Sox2, and Klf4 are likely to be direct targets of RNMT-RAM-dependent cap methylation. However, the dependency of transcripts on the m7G-cap for expression, processing, and translation is gene specific. Therefore, we performed an unbiased analysis of RAM-dependent genes, investigating transcript expression, polysome loading, and protein expression.

RAM Regulates the Expression of Transcripts Associated with Pluripotency {#sec2.4}
------------------------------------------------------------------------

In order to comprehensively identify RAM-dependent genes, we performed a RNA-sequencing (RNA-seq) transcriptome analysis of ESCs transfected with RAM siRNA or control in four biological replicates ([Figure S4](#mmc1){ref-type="supplementary-material"}B). In response to RAM suppression, from 12,803 genes that passed quality thresholds, 2,398 genes were downregulated and 2,569 upregulated (p value \< 0.05) ([Figure 3](#fig3){ref-type="fig"}A; [Table S1](#mmc2){ref-type="supplementary-material"}). A series of unbiased analyses were performed to determine whether these genes have related biological functions. Gene Ontology (GO) analysis of RAM-regulated transcripts determined that genes associated with developmental processes were among the most significantly enriched ([Figure 3](#fig3){ref-type="fig"}B). Gene set enrichment analysis revealed that RAM suppression resulted in significant repression of a set of genes previously implicated in ESC function (p value = 0.002) ([@bib6], [@bib10], [@bib15], [@bib26]) ([Figures 3](#fig3){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}). Suppression of components of the TFIID and Paf1 complexes, which mediate pluripotency-associated gene expression ([@bib31], [@bib32]), and the INO80 complex, which maintains open chromatin at pluripotency gene promoters, were also RAM regulated ([@bib43]) ([Figures 3](#fig3){ref-type="fig"}C and [S5](#mmc1){ref-type="supplementary-material"}). Statistically significant repression of Oct4, Klf4, and Nanog transcripts was observed.

Since RAM is reduced during neural differentiation, the contribution of RAM to gene expression changes concomitant with this process was investigated. Previously established ESC and neural-specific gene sets were analyzed (see [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"}). On RAM suppression, all established ESC-specific gene sets tested were significantly downregulated, and all established neuronal-specific gene sets tested were significantly upregulated, including genes activated during N2B27 neural differentiation ([Figures 3](#fig3){ref-type="fig"}D and 3E). Thus, high levels of RAM in ESCs are important for the expression of pluripotency-associated genes, and its repression contributes to the upregulation of neural-specific genes.

In order to ascertain the specificity that RAM imparts on RNA translation, the transcript content of polysomes was analyzed in response to RAM suppression ([Figure 2](#fig2){ref-type="fig"}B). Out of 12,803 genes analyzed, only 26 genes exhibited RAM-dependent changes in polysome loading normalized to input transcripts ([Figure 3](#fig3){ref-type="fig"}F; [Table S1](#mmc2){ref-type="supplementary-material"}). Therefore, RAM does not exhibit specificity over translational control and globally promotes ribosome loading.

Since suppression of RAM results in differential changes in transcript level and global changes in polysome loading, we investigated the resultant effect on the cellular proteome. A proteomic analysis of ESCs transfected with RAM siRNA in three biological replicates was performed using liquid chromatography-tandem mass spectrometry (LC-MS/MS) ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B). Proteins were identified and quantified using Maxquant software ([@bib14]) ([Table S2](#mmc3){ref-type="supplementary-material"}). Global proteomics studies have the caveat of identifying the most abundant and usually the most stable proteins; however, from the 2,617 proteins that passed quality thresholds, 59 were downregulated and 38 upregulated (p value FDR ≤ 0.05) ([Figure S6](#mmc1){ref-type="supplementary-material"}C; [Table S3](#mmc4){ref-type="supplementary-material"}). GO term analysis revealed that downregulated genes were enriched in categories including "gene expression," "RNA processing," and "translation" ([Table S4](#mmc5){ref-type="supplementary-material"}; [Figure S6](#mmc1){ref-type="supplementary-material"}D). Of note, the translation factors EIF4G1, EIF4G2, EIF3J1, and EIF6; ribosomal proteins RPL13a, RPL9, and RPS16; and tRNA synthetases WARS, CARS, and LARS were all found to be RAM regulated, which is likely to contribute to the global defects in translation ([Figure S7](#mmc1){ref-type="supplementary-material"}). The group of proteins significantly repressed in response to RAM suppression was significantly repressed at the transcript levels, indicating transcript-level control of these genes (p value = 0.01) ([Figure 3](#fig3){ref-type="fig"}G; [Table S5](#mmc6){ref-type="supplementary-material"}).

Repression of RAM Is Important for Neural Differentiation {#sec2.5}
---------------------------------------------------------

In ESCs, high levels of RAM are important for the expression of pluripotency-associated genes and suppression of RAM induces neural-associated genes. In order to determine whether the repression of RAM observed during neural differentiation contributes to this process, ESCs were engineered to constitutively express RAM-GFP from a plasmid under the control of a chimeric promoter ([Figures 4](#fig4){ref-type="fig"}A, 4B, and [S8](#mmc1){ref-type="supplementary-material"}A). These cells were morphologically indistinct from control ESCs ([Figure 4](#fig4){ref-type="fig"}A). During neural differentiation, RAM-GFP and endogenous RAM expression was maintained ([Figure 4](#fig4){ref-type="fig"}B). RAM-GFP-expressing cells exhibited some features associated with neural differentiation ([Figure 4](#fig4){ref-type="fig"}A) and increased Nestin transcripts ([Figure S8](#mmc1){ref-type="supplementary-material"}B).

During neural differentiation of ESC:RAM-GFP, the decrease in Klf4 protein expression was equivalent to that observed in ESCs ([Figure 4](#fig4){ref-type="fig"}B). However, expression of the pluripotency markers Oct4 and Sox2 was partially maintained in ESC:RAM-GFP during differentiation, whereas in control cells, their expression is repressed by day 6 ([Figures 1](#fig1){ref-type="fig"}, [4](#fig4){ref-type="fig"}B, and [S2](#mmc1){ref-type="supplementary-material"}A). Quantitation of four independent experiments revealed that Oct4 and Sox2 expression decreases during the initial days of differentiation; however, later during differentiation (days 5--9), Oct4 and Sox2 expression plateaus ([Figure 4](#fig4){ref-type="fig"}C). IF analysis indicated that preventing RAM repression delayed and impaired differentiation ([Figure 4](#fig4){ref-type="fig"}D). During differentiation of control ESCs, Oct4 expression was minimal by day 6, and expression of the neural marker tubulin III was observed in neurites on day 9. In ESC:RAM-GFP, Oct4 expression was distinct on day 6 and detectable on day 9, and tubulin III was visible on day 9 but less extensive compared to that seen in control cells.

RAM Expression Is Dependent on Oct4 and Sox2 {#sec2.6}
--------------------------------------------

Since RAM controls gene expression in ESCs and during neural differentiation, we investigated the mechanisms that regulate its expression. Initial investigation focused on the pluripotency-associated transcription factors Oct4, Sox2, Klf4, and Nanog ([Figures 5](#fig5){ref-type="fig"}A--5C). Inhibition of Oct4 and Sox2 expression by single or siRNA pool transfection resulted in a reduction in RAM protein expression, whereas inhibition of Klf4 and Nanog did not. Consistent with previous studies, transfection of Oct4 or Sox2 siRNA reduced expression of Klf4 and Nanog ([Figure 5](#fig5){ref-type="fig"}A) ([@bib15]). It is possible that RAM is repressed in response to severe disruption of this transcriptional network rather than specifically in response to Oct4 and Sox2 inhibition. Regulation of RAM expression did not appear directly transcriptional; suppression of Sox2 and Oct4 did not result in RAM transcript loss ([Figure S9](#mmc1){ref-type="supplementary-material"}), and RAM transcript loss did not accompany RAM protein loss during neural differentiation ([Figure 1](#fig1){ref-type="fig"}F). Characterization of RAM regulation focused on Sox2 rather than Oct4, since inhibition of later results in overt toxicity. The reduction in RAM expression resulting from Sox2 suppression was reversed by addition of a proteasome inhibitor MG132 ([Figure 5](#fig5){ref-type="fig"}D). Treatment with MG132 resulted in high molecular weight smear visible in the RAM western blot, consistent with an unstable pool of modified RAM. Furthermore, loss of RAM during neural differentiation was rescued by treatment with MG132, accompanied by high-molecular-weight RAM protein ([Figure 5](#fig5){ref-type="fig"}E).

Since covalent linkage of ubiquitin can mark proteins for degradation, we investigated whether RAM is ubiquitinated prior to degradation. RAM IPs from day 7 neural precursors included high-molecular-weight ubiquitinated protein, which increased following proteasome inhibition, consistent with an unstable pool of RAM-ubiquitin ([Figure 5](#fig5){ref-type="fig"}F). RAM was confirmed to be ubiquitinated by purification in denaturing conditions covalently linked to 6His-ubiquitin via nickel-charged resin ([Figure 5](#fig5){ref-type="fig"}G). When Sox2 expression was inhibited by siRNA transfection, RAM ubiquitination increased ([Figure 5](#fig5){ref-type="fig"}H). This result was observed with Fg-RAM and RAM-GFP, which were transfected and purified via their tags. Since ubiquitin conjugates to lysine residues, point mutations were made to map ubiquitination sites (K10N, K24R, and K31R; RAM 3K). K to R mutations are usually made to inhibit ubiquitination, but the K10N mutation was used, since this is a SNP. RAM 3K exhibited reduced ubiquitination, consistent with ubiquitin being conjugated to one or more of the mutated lysine residues ([Figure 5](#fig5){ref-type="fig"}I). Mapping RAM ubiquitination using single K mutants was attempted. However, some of these mutants were toxic and poorly expressed, precluding robust conclusions being drawn.

ERK1/2 Phosphorylation of RAM S36 Promotes Ubiquitination {#sec2.7}
---------------------------------------------------------

We characterized the signaling pathways that trigger RAM ubiquitination and degradation during differentiation. We observed that RAM is phosphorylated on serine 36 (S36) and investigated the impact of this modification on ubiquitination and degradation. ESC lines were created expressing Fg-RAM WT and S36A to ablate phosphorylation. Basal levels of Fg-RAM WT and S36A-ubiquitination were detected in untreated controls ([Figure 6](#fig6){ref-type="fig"}A). On MG132 treatment, Fg-RAM WT and S36A-ubiquitin increased, indicating that these ubiquitin conjugates are degraded by the proteasome in ESCs. Despite being expressed equivalently, Fg-RAM S36A exhibited reduced ubiquitination compared to WT, indicating that S36 phosphorylation is important (albeit not essential) for this modification. Note that the DMSO used as a vehicle control reduces basal RAM ubiquitination, the reasons for which are unclear, but DMSO is routinely observed to influence enzyme function.

In order to characterize RAM S36 phosphorylation, an antibody was raised against pS36, a RAM peptide phosphorylated on serine 36. The pS36 RAM antibody was phospho-specific, since it detected RAM-GFP wild-type (WT) and not S36A ([Figure 6](#fig6){ref-type="fig"}B), and the signal for endogenous RAM diminished following phosphatase treatment ([Figure 6](#fig6){ref-type="fig"}C). Since S36 is important for RAM ubiquitination, we investigated if RAM pS36 levels alter during neural differentiation. RAM pS36 was at the limit of detection until day 5, after which it was present, coincident with reduced total RAM levels ([Figures 6](#fig6){ref-type="fig"}D and [S2](#mmc1){ref-type="supplementary-material"}A). Since the S36A mutation results in decreased RAM ubiquitination, its effect on protein stabilization during differentiation was investigated. Expression of Fg-RAM S36A was equivalently to that observed in WT ESCs ([Figure 6](#fig6){ref-type="fig"}E). However, on day 6 of neural differentiation, Fg-RAM WT expression was reduced and partially rescued by proteasome inhibition, whereas RAM S36A was stable during differentiation ([Figure 6](#fig6){ref-type="fig"}E). Consistent with the expression of the markers of pluripotency, Oct4 and Sox2, being dependent on RAM, RAM S36A ameliorated their repression during neural differentiation ([Figure 6](#fig6){ref-type="fig"}F), similar to the effect of RAM-GFP ([Figure 4](#fig4){ref-type="fig"}).

RAM S36 lies in a potential recognition motif for several kinases, including ERK1/2, on which we focused, since it suppresses pluripotent gene expression ([@bib21], [@bib47]). Consistent with previous observations, active phospho-ERK1/2 peaked at day 5 during neural differentiation, when RAM pS36 and RAM degradation was first observed ([Figure 6](#fig6){ref-type="fig"}G) ([@bib30]). Recombinant ERK 2 phosphorylated recombinant RAM WT, but not RAM S36A, directly in vitro ([Figure 6](#fig6){ref-type="fig"}H). The pS36 antibody was further validated by the specific detection of ERK2-phosphorylated RAM ([Figure 6](#fig6){ref-type="fig"}I). In ESCs, inhibition of ERK activation using 1 μM PD0325901 on day 5 of neural differentiation inhibited RAM phosphorylation ([Figure 6](#fig6){ref-type="fig"}J). Sox2 inhibition resulted in increased RAM S36 phosphorylation, decreased expression ([Figure 6](#fig6){ref-type="fig"}K), and increased ubiquitination ([Figure 6](#fig6){ref-type="fig"}L), and PD0325901 reversed these effects.

Other kinases predicted based on substrate motif to be potential RAM S36 kinases (JNK, CDK1-cyclin B, CDK2-cyclin A1, and CDK3-cyclin E) did not detectably phosphorylate RAM in vitro and are therefore unlikely to phosphorylate RAM in cells ([Figure S10](#mmc1){ref-type="supplementary-material"}). However, since ERK1/2 activity is not maintained at high levels during differentiation, other kinases may phosphorylate RAM S36 at this time.

RNMT-RAM Upregulation Has a Role in Reprogramming {#sec2.8}
-------------------------------------------------

Since RAM is important for the expression of pluripotency-associated genes in ESCs, we investigated whether induction of pluripotency or "reprogramming" utilizes RAM. Initially, RNMT and RAM expression in ESCs, MEFs (mouse embryonic fibroblasts), and iPSCs (induced pluripotent stem cells) was compared. Strain 129/Ola MEFs were transduced with vectors expressing Oct4, Klf4, Sox2, and c-Myc ([@bib44]). Reprogrammed colonies (iPSCs) became visible as tightly packed clusters of embryonic stem-like cells, staining alkaline phosphatase (AP) positive and expressing Oct4, Sox2, c-Myc, and Nanog ([Figures 7](#fig7){ref-type="fig"}A, 7B, and 7D). In comparison to ESCs, MEFs contained less RNMT and RAM, and reprogramming to iPSCs restored expression of both ([Figure 7](#fig7){ref-type="fig"}B). The transcript level for RNMT and RAM was lower in MEFs than in ESCs and iPSCs, suggesting that a component of RNMT and RAM suppression is at the transcript level ([Figure 7](#fig7){ref-type="fig"}D). The same trend was observed with strain C57/BL6 MEFs and iPSCs (data not shown). RNMT and RAM expression was also reduced in human fibroblasts (hFs) compared to human ESCs (hESCs) and restored in human iPSCs ([Figure 7](#fig7){ref-type="fig"}C). As with MEFs, RNMT and RAM transcript level was reduced in human fibroblasts ([Figure 7](#fig7){ref-type="fig"}E).

We investigated the function of RNMT and RAM in MEF reprogramming. Reprogramming was induced by expression of Oct4, Sox2, Klf4, and c-Myc, which resulted in increased RAM expression after 5 days ([Figure 7](#fig7){ref-type="fig"}F). During reprogramming, RAM or RNMT expression was increased by overexpression of RAM-GFP or HA-RNMT and RAM-GFP on day 3 or 4, resulting in increased reprogramming efficiency ([Figure 7](#fig7){ref-type="fig"}G). Conversely, inhibition of RAM or RNMT expression by transfection of siRNA resulted in a reduction in iPSC colony formation ([Figure 7](#fig7){ref-type="fig"}H).

Discussion {#sec3}
==========

Differentiation of ESCs employs extensive coordinated regulation of transcription, RNA processing, translation, and protein modification to achieve the functional proteomes required of each lineage ([@bib15], [@bib27], [@bib33], [@bib40]). The cap is a potent mRNA modification with the potential to coordinate the expression of large cohorts of genes. We report that regulation of the mRNA cap methyltransferase RNMT-RAM makes a critical contribution to the gene expression changes required of differentiation and reprogramming. In vertebrates, the cap methyltransferase consists of RNMT, the enzymic subunit, and RAM, the activator subunit. High levels of RAM are found in ESCs, whereas in most murine organs, there is reduced or minimal expression. Focusing on the neural system, high levels of RNMT are present in brain tissue, cortical neurons, and in-vitro-differentiated neural progenitors, whereas there are minimal levels of RAM.

RAM Function in ESCs {#sec3.1}
--------------------

We addressed the biological significance of high RAM expression and cap methyltransferase activity in ESCs. In ESCs, ∼20% of genes analyzed were dependent on RAM for expression at the transcript level, including core pluripotency transcription factors, and pluripotency-associated transcriptional regulators and chromatin remodelers. The mRNA cap protects transcripts from degradation during transcription, and the cap methyltransferases have been demonstrated to promote transcription ([@bib41]). In addition, some transcript-level control may be a result of the indirect effects of RAM on transcriptional regulators.

In contrast to its specific effect on transcripts, in ESCs, RAM is a non-specific, global activator of translation. In response to RAM suppression, there was a significant loss of polysomal transcripts, but sequencing analysis revealed remarkably little selectivity to these genes. The mRNA cap binds to eIF4F, which recruits the transcript to the ribosome. However, our proteomic analysis revealed that RAM also regulates expression of translation factors, ribosomal subunits, and tRNA synthetases and thus may also regulate global translation indirectly.

Oct4 and Sox2 are two transcription factors required for pluripotency, and their repression is required for many programs of differentiation. In this paper, we demonstrate that Oct4 and Sox2 are RAM responsive. At the protein level, Oct4 and Sox2 are repressed in ESCs 2 days following transfection with RAM siRNA, and they are maintained during neural differentiation if RAM-GFP is expressed to prevent RAM repression. What is the mechanism of Oct4 and Sox2 regulation by RAM? We demonstrate that expression of Oct4 transcripts is dependent on RAM. In addition, Oct4 protein has a relatively short half-life, and therefore, although RAM inhibits polysome loading of all transcripts equivalently, proteins with short half-life are likely to be particularly responsive to translational inhibition ([@bib7]). Oct4 and Sox2 are also likely to be indirectly inhibited by suppression of RAM during differentiation. Repression of RAM inhibits expression of a large cohort of pluripotency-associated factors that may promote differentiation, repressing Oct4 and Sox2 as part of the process.

Gene Specificity of RAM {#sec3.2}
-----------------------

RAM not only activates RNMT catalytic activity but also recruits RNA to the methyltransferase via its RNA-binding domain. Prior to this study, RAM was thought to be a constitutive factor present on every RNMT protein, and therefore, whether the RNA binding domain has sequence specificity was not at the forefront of investigation ([@bib20]). Now that we recognize that there is a loss of RNMT-RAM heterodimers and gain of RNMT without RAM (probably monomers) during differentiation, the nature of RAM-RNA binding specificity becomes key to understanding its function. Since sequencing analysis indicated that a subset of transcripts were dependent on RAM for expression, this suggests that RAM does have sequence, motif, or chromatin context specificity.

RAM Expression Control {#sec3.3}
----------------------

The kinase ERK1/2 is upregulated during differentiation and is an established suppressor of pluripotency-associated genes ([@bib8], [@bib21], [@bib35]). ERK1/2 phosphorylates RAM S36, triggering ubiquitination and proteosomal degradation. Phospho-S36 may recruit an E2/E3 ligase that ubiquitinates RAM or inhibits interaction with a deubiquitinating enzyme. Our findings are consistent with ERK1/2-dependent repression of RAM being an important contributor to the mechanism by which it represses pluripotency-associated genes ([@bib8]).

ERK1/2 specifically targets RAM for degradation, leaving RNMT intact. RNMT and RAM interact with high affinity, and RAM monomers are not readily observed in cells, and therefore, the specific targeting of RAM is mechanistically surprising. However, our in vitro kinase assays revealed that ERK2 only phosphorylates monomeric RAM and not RAM in complex with RNMT. In the RNMT-RAM structure, RAM S36 is partially buried in RNMT and therefore inaccessible as an ERK1/2 substrate (unpublished data). Thus, ERK1/2 is able to specifically target newly synthesized monomeric RAM for degradation, leaving existing RNMT-RAM and nascent RNMT monomers intact.

RAM-ESC Gene Regulatory Network Feedback Provides Robustness to Pluripotency {#sec3.4}
----------------------------------------------------------------------------

Here, we describe a positive feedback loop between RNMT-RAM and pluripotency-associated gene expression, which we postulate provides robustness to pluripotency and differentiation. High levels of RAM result in the expression of a large cohort of pluripotency associated genes. Should pluripotency-associated transcript levels fluctuate in ESCs, high levels of RNMT-RAM will maintain their expression. However, when the trigger for differentiation is sustained, these transcripts may fall below a threshold at which RNMT-RAM cannot maintain their expression. At this point, ERK1/2 activity increases, RAM becomes phosphorylated, ubiquitinated, and degraded, and RAM-dependent pluripotency-associated genes are repressed, permitting differentiation. Thus, RNMT-RAM is a critical component of the pluripotency network.

Experimental Procedures {#sec4}
=======================

ESC Culture {#sec4.1}
-----------

46C ESCs (expressing Sox1-GFP) derived from strain 129Ola mice were cultured on 0.1% gelatin-coated dishes in Glasgow minimal essential medium (Sigma), 10% knockout serum replacement, 1% modified Eagle's medium (MEM) non-essential amino acids, 1 mM sodium pyruvate (Life Technologies), 0.1 mM 2-mercaptoethanol (Sigma), and 100 U/ml recombinant human leukemia inhibitory factor). hiPS4 and SA181 human ESC lines purchased from Cellartis and maintained in DEF-CS (Cellartis). Human neural differentiation was performed as described previously ([@bib9]), except that cells were seeded at a density of 6 × 10^4^ cells/cm^2^ on Matrigel (20 μg/cm^2^) and grown for 48 hrs in cell medium before switching to differentiation media. Murine neural differentiation was performed as described previously ([@bib35], [@bib47]). 0.5--1.5 × 10^4^/cm^2^ ESCs were plated on 0.1% gelatin-coated dishes in N2B27 (DMEM/F12; Gibco) supplemented with modified N2 (25 μg/ml insulin, 100 μg/ml apo-transferrin, 6 ng/ml progesterone, 16 μg/ml putrescine, 30 nM sodium selenite and 50 μg/ml BSA fraction V; Gibco). Medium was renewed every 2 days.

Primary Neural Cell Culture {#sec4.2}
---------------------------

Primary cortical neurons established from E16 mice (strain C57Bl) are a mixed population of terminally differentiated neurons from the cortex. Primary neuronal cells were plated onto 10 μg/ml poly-L-lysine-coated flasks and maintained in Neurobasal medium with B27 supplement (Life Technologies), 2 mM glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin (Lonza). Astrocytes are dividing cells of the astroglial line, established from P2. Astrocytes were maintained in DMEM/10% fetal calf serum until confluent.

Transfections {#sec4.6}
-------------

1 × 10^5^ cells transfected with 200 pmol siRNA or non-targeting controls (siGenome, Dharmacon) using Lipofectamine 2000 (Invitrogen). 1 × 10^6^ ESCs in a 10-cm dish transfected with 4 μg pPyPCAGIP plasmids using Fugene HD (Promega) or Lipofectamine 2000 (Life Technologies). 1 μg/ml puromycin was used for selection.

Reprogramming {#sec4.3}
-------------

1.5 × 10^5^ MEFs were plated on a six-well plate well. 1.5 μg PB-TAP IRI 2OKSMimO (expressing Oct4, Klf4, Sox2, c-Myc), AG-rtTA (reverse tetracycline transactivator), and HyPBase (transposase) was transfected using Fugene HD (Invitrogen) ([@bib25], [@bib44]). At day 3 or 4, cells were transfected with 200 pmol RAM siRNA, 1 μg pPyPCAGIP RAM-GFP, or 0.5 μg pPyPCAGIP RAM-GFP and 0.5 μg pPyPCAGIP HA-RNMT. Induced pluripotent cell colony number was counted following AP staining after 14 days of reprogramming.

Statistics {#sec4.4}
----------

Statistical methodologies are reported in figure legends and in proteomics and RNA-seq experimental procedures.

See [Supplemental Experimental Procedures](#mmc1){ref-type="supplementary-material"} for polysome profile and RNA-seq analysis, proteomics analysis, molecular biology, immunological techniques, kinase assay, and description of expression construct.
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![Expression of RAM Is Suppressed during Murine Neural Differentiation\
(A) Mouse organ and murine ESC extracts analyzed by western blot (WB). Ponceau S was used to stain PVDF membranes.\
(B) ESCs, primary cortical neurons, and primary astrocytes extracts analyzed by WB. ESCs were cultured according to a 9-day neural differentiation protocol.\
(C) Phase-contrast images of cultures. Scale bar, 100 μm.\
(D) Proteins, including Sox1 (GFP reporter), were detected by immunofluorescence (IF). Scale bar, 10 μM. DAPI DNA stain was used.\
(E) Proteins detected by WB.\
(F) Transcripts detected by RT-PCR, normalized to Actin. Data represent an average of three independent experiments, and error bars indicate SD.\
See also [Figures S1--S3](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![RAM Is Important for Oct4, Sox2, and Klf4 Expression\
(A) ESCs transfected with three independent siRNAs, pool, or a non-targeting control for 48 hr.\
(B) RNA-protein complexes resolved through sucrose gradient. RNA was purified and quantitated. Mean and SEM of four independent experiments are presented.\
(C) Relative ratio of monosomes to polysomes.\
(D) ESCs infected with lentiviruses carrying RAM or control small hairpin RNAs (shRNAs), seeded at clonal density, and stained for alkaline phosphatase (AP) after 7 days. Over 290 colonies were scored in three independent experiments, and average percent AP positive, mixed, or negative colonies are reported.\
(E) ESCs were transfected with RAM or control siRNA for 48 hr and fixed, and proteins were detected by IF. Scale bar, 10 μm.\
(F) Quantitation of average cellular staining in five independent fields (ImageJ software). Data are representative of two independent experiments.\
(G) For at least three independent experiments, average protein level relative to actin was detected by WB and quantitated.\
(H) Anti-m7G antibodies or matched controls used to immunoprecipitate m7G-RNA (RT-PCR analysis).\
(C, D, G, and H) Error bars indicate SD for at least three independent experiments. t test p value relative to control (^∗^p \< 0.05; ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001).\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr2){#fig2}

![RAM Regulates a Subset of Pluripotency-Associated Genes\
(A) Summary of siRAM/control RNA-seq analysis. Number of up- and downregulated genes, scatterplot of transcript log2 fold change (logFC) against transcript abundance (log2 counts per million \[logCPM\]), and data distribution are shown. RAM and Actin are marked. p \< 0.05 represents corrected p value \< 0.05.\
(B) Most enriched GO Biological Process terms for genes up- or downregulated at least 0.5 logFC.\
(C) RAM siRNA-induced transcript changes of pluripotency-associated factors (barcode plot). See also [Figure S5](#mmc1){ref-type="supplementary-material"}.\
(D) RAM siRNA-induced directional transcript changes for ESC- or neural-specific gene sets (see [Experimental Procedures](#sec4){ref-type="sec"} for a sets description).\
(E) Boxplot representation of (D). p values (false discovery rate \[FDR\]) are log10 transformed and shown below or above axis for down- or upregulated gene sets, respectively.\
(F) Scatterplot of expression changes at transcript and polysome level.\
(G) Boxplot of transcript changes of proteins unchanged (unsig.), downregulated, or upregulated in mass spectrometry analysis ([Figure S6](#mmc1){ref-type="supplementary-material"}). Gene set tests performed with ROAST (see [Experimental Procedures](#sec4){ref-type="sec"}). ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. Boxplot whiskers span from the 5th to 95th percentiles.\
See also [Figures S5--S7](#mmc1){ref-type="supplementary-material"}.](gr3){#fig3}

![Sustained RAM Expression Maintains Pluripotency Markers during Differentiation\
(A) ESC:RAM-GFP or control cultured in a 9-day neural differentiation protocol. Phase-contrast images are shown. Scale bar, 100 μm.\
(B) Protein detected by WB.\
(C) Oct4 and Sox2 protein level quantitated in three independent experiments. Mean and SD are presented.\
(D) Oct4 and tubulin III detected by IF.\
See also [Figure S8](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![RAM Is Ubiqutinated and Degraded by the Proteasome\
(A--C) Expression of Oct4, Sox2, Klf4, and Nanog inhibited by transfection of siRNA pools (A) or independent siRNAs (B and C) for 72 hr. Proteins were detected by WB.\
(D) ESCs were transfected with Sox2 siRNA for 72 hr, then 1, 2, or 5 μM MG132 was added for the time indicated. WB analysis is shown. LE indicates long exposure, and the asterisk (^∗^) indicates high-molecular-weight protein.\
(E) ESCs subject to neural differentiation. On day 6, cells were treated with 2 μM MG132 or DMSO control for 3 hr.\
(F) Neural differentiation on day 7. Immunoprecipitations were performed on cell extracts using anti-RAM or control antibodies. Asterisk (^∗^) indicates high-molecular-weight ubiquitinated proteins detected by WB. LC, light chain; HC, heavy chain.\
(G) ESCs expressing 6His-ubiqutin (6His-Ubq) or control (c) incubated in 2 or 5 μM MG132 for 4 hr. Extracts subject to Ni-NTA agarose pull-down and WB.\
(H) ESC:Fg-RAM or RAM-GFP transfected with Sox2 siRNA for 72 hr. Fg-RAM and RAM-GFP were purified via tags. RAM and high-molecular-weight ubiquitinated protein was detected by WB.\
(I) As in (H), except Fg-RAM WT and 3K were expressed.\
See also [Figure S9](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![ERK-Dependent S36 Phosphorylation Targets RAM for Degradation during Differentiation\
(A) Fg-RAM WT or S36A purified from ESCs treated with 5 μM MG132, DMSO control, or untreated for 3 hr. RAM and ubiquitinated protein detected by WB.\
(B) RAM-GFP WT and S36A and GFP alone (purified) and WBs were performed to detect pS36 RAM and total RAM.\
(C) ESC extracts treated with lambda phosphatase for the time indicated, and pS36 RAM and total RAM were detected.\
(D) ESCs subjected to neural differentiation protocol. Extracts were analyzed by WB on the days indicated.\
(E) Fg-RAM WT and S36A expressed in ESCs. ESCs and day 6 neural precursors, pre-treated with 2 μM MG132 or DMSO control for 3 hr, were analyzed by WB.\
(F) As in (E), except expression of Oct4, Nanog, and Sox2 was analyzed in day 5 neural precursors.\
(G) Expression of pERK1/2 and ERK1/2 analyzed by WB during neural differentiation.\
(H) 50 ng ERK2 incubated with 1 μg GST-RAM WT or S36A and ^32^PATP for 1 hr at 37°C. Phosphorylated protein was detected by film. GST-RAM was visualized by Coomassie staining.\
(I) 10 ng GST-RAM subject to in vitro kinase assay with ERK2 or control analyzed by WB.\
(J) Day 5 neurodifferentiated cells treated with 1 μM PD0325901 for the time indicated and proteins detected by WB.\
(K) ESCs transfected with Sox2 siRNA or control for 72 hr and treated with 1μM PD0325901or DMSO for 12 hr. Extracts were analyzed by WB.\
(L) As in (K), except cells were treated with 2 μM MG132 for 2 hr prior to WB analysis. Top: RAM was immunoprecipitated and ubiquitin detected.\
See also [Figure S10](#mmc1){ref-type="supplementary-material"}.](gr6){#fig6}

![High Levels of RNMT-RAM Are Required for Pluripotency\
(A) Murine ESC, MEFs, and iPSCs were AP stained. Scale bar, 200 μm.\
(B) Proteins analyzed by WB.\
(C) Proteins analyzed by WB in extracts from human ESCs (hESC), human fibroblasts (hF), and human iPSCs (hiPS).\
(D and E) Average transcript level for three independent experiments detected by RT-PCR in murine ESCs, MEFs, and iPSCs (D) and hESCs, hFs, and iPSCs (E).\
(F) Oct4, Klf4, Sox2, and c-Myc expressed in MEFs and transcript levels detected on the days indicated.\
(G and H) After 3--4 days, cells were also transfected with vectors to express RAM-GFP, or RAM-GFP and HA-RNMT (G) or cells were transfected with RNMT or RAM siRNA (H). After 14 days, the relative number of colonies with ESC-like morphology and AP-positive colonies was scored. Mean and SD for three independent experiments are shown. t test p values calculated relative to control (^∗^p ≤ 0.05). Representative wells of AP-stained iPSC colonies.](gr7){#fig7}
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